靶点针对疾病信息70(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
INDICATI
Approved Hypotension [ICD-11: BA20-BA21]
INDICATI
Approved Inborn porphyrin/heme metabolism error [ICD-11: 5C58]
INDICATI
Approved Insomnia [ICD-11: 7A00-7A0Z]
INDICATI
Approved Itching [ICD-11: 1F28-1G07]
INDICATI
Approved Migraine [ICD-11: 8A80]
INDICATI
Approved Nausea/vomiting [ICD-11: MD90]
INDICATI
Approved Pain [ICD-11: MG30-MG3Z]
INDICATI
Approved Parkinsonism [ICD-11: 8A00]
INDICATI
Approved Pituitary gland disorder [ICD-11: 5A60-5A61]
INDICATI
Approved Postpartum haemorrhage [ICD-11: JA43]
INDICATI
Approved Psychotic disorder [ICD-11: 6A20-6A25]
INDICATI
Approved Sexual dysfunction [ICD-11: HA00-HA01]
INDICATI
Approved Substance abuse [ICD-11: 6C40]
INDICATI
Approved Thyrotoxicosis [ICD-11: 5A02]
INDICATI
Approved Type 2 diabetes mellitus [ICD-11: 5A11]
INDICATI
Phase 3 Choreiform disorder [ICD-11: 8A01]
INDICATI
Phase 3 Lung cancer [ICD-11: 2C25]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3